You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 29, 2024

List of Excipients in API EMTRICITABINE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing EMTRICITABINE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Physicians Total Care Inc EMTRIVA emtricitabine 54868-4853 CELLULOSE, MICROCRYSTALLINE
Physicians Total Care Inc EMTRIVA emtricitabine 54868-4853 CROSPOVIDONE
Physicians Total Care Inc EMTRIVA emtricitabine 54868-4853 FD&C BLUE NO. 2
Physicians Total Care Inc EMTRIVA emtricitabine 54868-4853 GELATIN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Try a Trial

Detailed excipient profiles for EMTRICITABINE

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: CALCIUM STEARATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERYL CAPRYLATE/CAPRATE

Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE

EMTRICITABINE drug variants containing GLYCERYL MONOCAPRYLOCAPRATE

Company Ingredient NDC
American Health Packaging emtricitabine and tenofovir disoproxil fumarate 60687-719
Redpharm Drug Inc emtricitabine and tenofovir disoproxil fumarate 67296-1830
Zydus Pharmaceuticals USA Inc emtricitabine and tenofovir disoproxil fumarate 70710-1364
Zydus Pharmaceuticals (USA) Inc emtricitabine and tenofovir disoproxil fumarate 70710-1367
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: KAOLIN

Excipient focus: LACTOSE MONOHYDRATE

EMTRICITABINE drug variants containing LACTOSE MONOHYDRATE

Company Ingredient NDC
Teva Pharmaceuticals USA Inc emtricitabine and tenofovir disoproxil fumarate 0093-7607
Teva Pharmaceuticals USA Inc emtricitabine and tenofovir disoproxil fumarate 0093-7704
Mylan Pharmaceuticals Inc emtricitabine and tenofovir disoproxil fumarate 0378-1930
Major Pharmaceuticals emtricitabine and tenofovir disoproxil fumarate 0904-7172
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

EMTRICITABINE drug variants containing MICROCRYSTALLINE CELLULOSE 102

Company Ingredient NDC
Camber Pharmaceuticals Inc emtricitabine and tenofovir disoproxil fumarate 31722-560
Zydus Pharmaceuticals (USA) Inc emtricitabine and tenofovir disoproxil fumarate 70710-1367
Cadila Healthcare Limited emtricitabine and tenofovir disoproxil fumarate 70771-1594
DIRECT RX emtricitabine and tenofovir disoproxil fumarate 72189-227
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: MICROCRYSTALLINE CELLULOSE 200

Excipient focus: MICROCRYSTALLINE CELLULOSE 301

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 20

EMTRICITABINE drug variants containing POLYSORBATE 20

Company Ingredient NDC
Gilead Sciences Inc emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide 61958-2101
Physicians Total Care Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 54868-6360
Gilead Sciences Inc emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 61958-1101
REMEDYREPACK INC emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate 70518-0677
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONE K90

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STEARYL FUMARATE

EMTRICITABINE drug variants containing SODIUM STEARYL FUMARATE

Company Ingredient NDC
American Health Packaging emtricitabine and tenofovir disoproxil fumarate 60687-719
Redpharm Drug Inc emtricitabine and tenofovir disoproxil fumarate 67296-1830
Zydus Pharmaceuticals USA Inc emtricitabine and tenofovir disoproxil fumarate 70710-1364
Zydus Pharmaceuticals (USA) Inc emtricitabine and tenofovir disoproxil fumarate 70710-1367
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - HIPAA-ready chat for life sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group